United States· US:50742-659_514dd27c-d315-4775-91d2-a58ac2293edc
Dolishale
A medicinal product containing levonorgestrel; ethinyl estradiol, registered in United States by Ingenus Pharmaceuticals, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LEVONORGESTREL; ETHINYL ESTRADIOL
- Manufacturer
- Ingenus Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1150742-659-28
- ndc1150742-659-68
- ndc1150742659281 BLISTER PACK in 1 CARTON (50742-659-28) / 28 TABLET in 1 BLISTER PACK
- ndc1150742659686 BLISTER PACK in 1 CARTON (50742-659-68) / 28 TABLET in 1 BLISTER PACK
- ndc1150742659843 BLISTER PACK in 1 CARTON (50742-659-84) / 28 TABLET in 1 BLISTER PACK
- ndc1150742-659-84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levonorgestrel; ethinyl estradiol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyAsumate 20Exeltis Germany Gmbh
- SwitzerlandEffilevo 0.10 mg / 0.02 mg, comprimés pelliculésEFFIK SA
- SpainAILEVA 0,1 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGLaboratorios Cinfa S.A.
- CzechiaASUMATEExeltis Czech s.r.o., Praha
- United KingdomAmbelina 150microgram/30microgram tabletsCrescent Pharma Ltd
- FranceADEPAL, comprimé enrobéPFIZER HOLDING FRANCE
- NetherlandsEthinylestradiol/Levonorgestrel 0,02 mg/0,10 mg Focus, filmomhulde tablettenFocus Care Pharmaceuticals B.V.
- CanadaALESSE 21PFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Erlidona, Ethinylestradiol/Levonorgestrel Nextpharma
- Belgium · Eleonor 20, Lavinia
- Bulgaria · Три-Регол
- Czechia · Ebelya, Minisiston
- Germany · Asumate 20, Asumate 30
- Denmark · Anastrella, Femicept
- Spain · Aileva, Anaomi
- France · Adepal, Asterluna
- United Kingdom (Northern Ireland) · Ambelina, Elevin
- Croatia · Adexa
- Hungary · Rigevidon, Seasonique
- Ireland · Leonore, Levonorgestrel/ Ethinylestradiol Renata Pharmaceuticals (Ireland)
- Iceland · Levoethin, Melleva
- Italy · Egogyn, Lasca
- Lithuania · Rigevidon, Tri - Regol
- Luxembourg · Levorichter 30, Lowette
- Latvia · Rigevidon
- Netherlands · Ethinylestradiol/Levonorgestrel Ceres Pharma, Ethinylestradiol/Levonorgestrel Focus
- Norway · Melleva, Microgynon
- Poland · Levomine, Levomine Mini
- Portugal · Effilevo, Etinilestradiol + Levonorgestrel Generis
- Romania · Microgynon, Seasonique
- Sweden · Anastrella, Leverette 21
- Slovenia · Stediril-M
- Slovakia · Ebelya, Seasonique
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a349506b-85de-4301-93eb-ce06c4e114d2 GET /v1/drugs/a349506b-85de-4301-93eb-ce06c4e114d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "90; 20",
"substance": "LEVONORGESTREL; ETHINYL ESTRADIOL",
"productndc": "50742-659",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "ug/1; ug/1",
"application_number": "ANDA091692",
"marketing_category": "ANDA"
}See everything about levonorgestrel; ethinyl estradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.